Stock PKBO PEAK BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Peak Bio, Inc.

Equities

PKBO

US70470P1084

Delayed OTC Markets
Other stock markets
 01:11:26 2024-05-30 pm EDT 		5-day change 1st Jan Change
0.0086 USD -.--% Intraday chart for Peak Bio, Inc. -.--% -95.41%
Mar. 05 Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. CI
Feb. 16 Peak Bio, Inc. announced that it has received $2.238 million in funding CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Initiates Peak Bio at Buy Rating With $15 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PKBO Stock
  4. News Peak Bio, Inc.
  5. Analyst Reco.